chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling of lymph node in right armpit originally. Swelling and fluid spread - filling right side of body, across right collar bone, halfway down torso and slightly around the back. It also spread down the right arm halfway to elbow. The on-call nurse originally thought it could be cellulitis but after being told there was no redness or itchiness, she was unsure of the diagnosis and suggested to talk with the on-call doctor or go to the ER. The on-call doctor really had no idea as to what was going on. Once at the ER, the doctor checked with other doctors and read as much as he could about this type of reaction. Nothing he read matched up exactly with what was going on. He did note some swelling of lymph nodes had been reported but not to this extent. With all this being new, he suggested to go home and watch the swelling and come back if things got worse. For several days, there continued to be no redness or itchiness. The discomfort was only in the lymph node in the right armpit, with some slight pressure from the skin tightening around the fluid on the arm. Within a week, the welling was completely gone and the lymph node discomfort lasted a couple days more.     I feel it necessary to note that I don't believe the shot was given in the correct location. As soon as the needle entered the skin, my thought was 'that is too high' and there was a pain like I have never felt with a vaccine before. That pain subsided shortly after the injection but it was several days before the injection site felt better. Now, two weeks later, I have a constant pain in my shoulder, slightly down my arm and into my collar bone area. There are also times when the pain throbs or shoots through as well.  I believe this pain may be due to the placement of the shot, and not necessarily from the vaccine itself.
This spontaneous report was received from a nurse and refers to a 26 year old female patient. The patient had no concomitant medications or pertinent medical history. The patient was allergic to cranberries. On 30-APR-2018, the patient was vaccinated with first dose of GARDASIL 9 intramuscularly into right deltoid (lot # N026812, expiration date: 22-JUN-2020, dose and frequency were not provided) for HPV prevention. On 30-APR-2018, the patient experienced burning/tingling in the palm of her right hand. The patient sought medical attention. Nurse practitioner wanted to know if the patient could be administered a second dose of GARDASIL 9 after experiencing burning and tingling in the palm of her hand. The outcome of burning/tingling in the palm of her right hand was reported as recovered/resolved. The patient sought medical attention. The causal relationship between the events and suspected vaccine was not provided.
positive for COVID 6 days post first dose/Sore throat/body aches; positive for COVID 6 days post first dose/sore throat/body aches; This is a spontaneous report from a contactable nurse. This report was received via a Pfizer Sales Representative. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date (reported as a Thursday) at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received first shot on a Thursday. 5 days later patient was exposed to a COVID patient. Patient got tested for COVID-19 and tested positive for COVID 6 days post first dose. Day 7 post dose experienced sore throat and body aches. Events took place after use of product. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 virus test positive and drug ineffective due to temporal relationship.  This case will be reassessed once additional information is available.
JOHNSON AND JOHNSON VACCINE KILLED BEST FRIEND; This spontaneous report received from a consumer via a company representative via media concerned a patient of unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: UNKNOWN) dose was not reported, 1 total, start therapy date was not reported for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient died. The patient died from unknown cause of death. It was reported as "Johnson and Johnson vaccine killed my best friend". It was unknown whether autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: 20221209949- Johnson and Johnson vaccine killed my best friend. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
A few hours after (vaccine) administered, right thigh had significant swelling, diffuse, erythema, increased warmth, and mild tenderness, examined 12/10/03 11 AM.
On the 13th, I felt lethargic and "out of it" all day, more specifically -  weak and dizzy when up and walking around.  I felt very warm all day, and because of the other symptoms, I didn't think to take my temperature until later that afternoon. I didn't have a  proper thermometer, so I took my temperature under my arm with a scientific field thermometer - it registered approximately 104.5 degrees - between 104-105 degrees Fahrenheit. This was the best measurement I could get as the thermometer is graduated every 2 degrees (i.e., I was reading between 104-106). My regular "medical" thermometer had a dead battery.  I didn't seek treatment, but took 2-200mg tablets of ibuprofen every 4 hours  (4pm, 8pm, then again at 8am the next day).  The second day (9/14), I took my temperature again and it had come down to a little over 100 degrees. I took the last ibuprofen dose of 400mg at that time.
Evening of immunizations, left arm became red covering area and surrounding skin, hot to touch with nausea on an off. No fever. Mom gave total of 2 doses of Motrin as prophylactic day of shots.
Had a hard time getting sleep; My left eye got seriously inflamed/ left eye became extremely red, inflamed; Eye was red, and still swollen/ left eye became extremely red, inflamed; Eye was red, and still swollen; Painful/ Eye is still sore/still having the pain in it but not intense; This is a spontaneous report from a contactable consumer (patient). An 85-years-old female patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN5318), via an unspecified route of administration on 29Jan2021 at 01:15 at single dose for to protect me against COVID. Medical history included blood pressure and muscular degeneration in eye. Concomitant medication included hydrocodone (trade name not reported) for blood pressure. The patient experienced my left eye got seriously inflamed/ left eye became extremely red, inflamed, eye was red, and still swollen/ left eye became extremely red, inflamed, eye was red, and still swollen, painful/ eye is still sore/still having the pain in it but not intense on 29Jan2021 and had a hard time getting sleep on an unspecified date. Outcome of the events eye was red, and still swollen and painful/ eye is still sore/still having the pain in it but not intense was not recovered and other events were unknown.
A nurse reported a pt received an injection of Flu Shield '00-'01 on 11/16/00 and subsequently developed an injection site reaction characterized by a "hard knot".
Initial report was received on 25 October 2011 from a health care professional. A one year-old patient who was well at the time of vaccination had received on 17 October 2011 an intramuscular right arm injection of FLUZONE, lot number U4159BB and an unspecified amount of later, experienced difficulty walking and would drop to the floor. The patient was diagnosed with cerebellitis, possibly from vaccination. Treatments and diagnostic tests were not reported. The patient had received on 13 September 2011 an intramuscular left arm injection of PREVNAR 13, Pfizer lot number 916973. The patient's pre-existing conditions and adverse events following prior vaccinations were reported as none. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Received DTaP (R) thigh 7-26-12; Evening of 7-27-12 redness, swelling, warmth at site of injection. Today induration/erythema 6" x 6" very tender.
persistent cough, like a coughing spam that was persistent and it was; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (persistent cough, like a coughing spam that was persistent and it was) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product DUPILUMAB for Asthma.    Concurrent medical conditions included Asthma.   On 28-Apr-2021, the patient started DUPILUMAB (Subcutaneous) 300 milligram every two weeks. In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (persistent cough, like a coughing spam that was persistent and it was). The patient was treated with BUDESONIDE for Cough, at a dose of 1 UNK. At the time of the report, COUGH (persistent cough, like a coughing spam that was persistent and it was) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had two doses of dupilumab, then he received his first Moderna shot (date unknown) and two weeks later, On 26-May-2021, Patient took third shot of  dupilumab.
I felt really lethargic and fatigued, like I had been drugged. About 12 hours later I got rigors, cold sweat. I didnt check my temperature but I feel like I had a fever. I took and Advil which did help. I was able to sleep about 3am and then I slept a ton and had to miss work the next day. My left arm on the upper side and back was incredibly sore. I couldn't even lay on my left side, the selling persisted for about a week.  I have had  way more fatigue since then. 2 upper respiratory infections back to back. I do not get sick like that ever. I just found out that I am now pregnant.
I had no symptoms after the vaccine. On Nov 24th, I went to an event and three people tested positive and on 11/29 my wife tested positive. On Dec 14th I had a home COVID-19 test and I tested positive. I had very slight coughing and congestion. I called the doctor and prescribed medications; I took them for 5 days.
This is a spontaneous report from a non-contactable nurse practitioner (reporting on behalf of her son) via a Pfizer sales representative.  A 19-year-old male patient received TRUMENBA (lot R45077) at single dose for immunization on unknown date. Medical history and concomitant medications were unknown. On unknown date the patient experienced redness by injection site that travel down his arm. The outcome of the event was unknown. No follow-up attempts are possible. No further information is expected.
Difficulty to pee; High Fever; Very tired; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder (on medications.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSURIA (Difficulty to pee), PYREXIA (High Fever) and FATIGUE (Very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was on unspecified medications.
This is a spontaneous report received from a contactable consumer or other non-HCP (the patient). A 58-year-old male patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# EW0196), at the age of 57, in left arm, Jun 2021, single dose, for COVID-19 immunization. Medical history included anxiety (unspecified if ongoing). Concomitant medication included diazepam taken for anxiety. The patient experienced abnormal thinking/avalanche of different thoughts and tachyphrenia/racing thoughts, with outcome of recovered. No therapeutic measures taken as a result of abnormal thinking and tachyphrenia. Additional information: It was reported when he got his first Pfizer vaccine, he had racing thoughts. He could not control his thoughts. He had multiple thoughts. Sender's comments: Linked reports: US-PFIZER INC-202200986923 (same reporter/drug/events/patient, different dose); US-PFIZER INC-202200986924 (same reporter/drug/event, different patient).
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The patient was intramuscularly vaccinated with the first dose of 0.5 ml GARDASIL (lot number not provided) on an unspecified date, a second dose of GARDASIL 4 months later and a third dose of GARDASIL 2 months after the second dose. No other co-suspects were reported. NO concomitant medications were reported. No adverse effect reported. It was unspecified if the patient had sought medical attention. Additional information is not expected.
THE VACCINE WAS STORED IN THE FRIDGE AFTER PUNCTURE FOR ABOUT 20 HOURS; THE VIAL WAS PUNCTURED THE PREVIOUS DAY, THE PUNCTURED VIAL WAS USED AT LEAST 20 HOURS AFTER IT WAS FIRST PUNCTURED; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, intramuscular, batch number: 207A21A, expiry: UNKNOWN) dose was not reported, administered on 03-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 03-SEP-2021, the patient experienced the vial was punctured the previous day, the punctured vial was used at least 20 hours after it was first punctured. On an unspecified date, the patient experienced the vaccine was stored in the fridge after puncture for about 20 hours. The action taken with covid-19 vaccine was not applicable. The outcome of the the vial was punctured the previous day, the punctured vial was used at least 20 hours after it was first punctured and the vaccine was stored in the fridge after puncture for about 20 hours was not reported. This report was non-serious.
11/13/15 PE. Child had gagging/choking episode after RV5 with short apnea episode < 30 sec. Again gag/choking episode after inject. 4 mo IMS. Observed 90 min in clinic. 11/15/15 ER with emesis after every feed. Pt admitted for observation abd US showed intussusception. Reduced with GASTROGRAFIN. Dsch 11/16/15.
Pt has local swelling and bruising in the area of the vaccine. Swelling occured the next day and was reported as painful. Swelling went away, but still some bruising at site of injection.
pt recv vax 8NOV95 & failed to seroconvert;no further details were provided;
sore arm after both doses; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm after both doses) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Blood pressure abnormal.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm after both doses). At the time of the report, PAIN IN EXTREMITY (sore arm after both doses) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant informations were reported.  No treatment informations were reported.   This case was linked to MOD-2021-392132 (Patient Link).
Lymphadenopathy/swollen lymph nodes; Fever; Fatigue; This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Lymphadenopathy/swollen lymph nodes), PYREXIA (Fever) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Lymphadenopathy/swollen lymph nodes), PYREXIA (Fever) and FATIGUE (Fatigue). At the time of the report, LYMPHADENOPATHY (Lymphadenopathy/swollen lymph nodes), PYREXIA (Fever) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant medication was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-058228 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-058228:
erythematous rash face trunk extremities, periorbital edema; cleared w/1 dose of DPH;
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2008, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2015, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is considered to be not recovered. Additional information has been requested.
Covid after first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Covid after first dose) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid after first dose). At the time of the report, COVID-19 (Covid after first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Treatment information was not provided.
Extreme soreness which prevents the movement of my arm in all directions without causing sharp pain. I also got bruising in the area with redness (small bumps) around injection site.
Shortness of breath  had shot at 8:25 and at 11 am took emergency meds Inhaler didnt help added a diamond chamber to inhaler took hydroxyzine hcl 25 mg and relieved symptoms. Called my doctor at the clinic no answer messaged them said if worsened go to ER or come in. As emergency meds worked went to bed
Very high heart rate and blood pressure , fever over 101, body aches and chills. Inability to stand or eat
As with the first two Moderna vaccines, I experienced numbness of the face and lips which began on my drive home. This time it lasted less long. But this time I also experienced flu-like symptoms about nine hours later: body aches, uncontrollable shivering and chills, fever, headache. The flu-like symptoms lasted a good 24 hours once they began at 11:00 PM. This side effect did not happen with the first two vaccinations. I have ALSO been suffering from what feels like burning in the roof of my mouth since last summer - wondering if this was caused by the vaccines since the numbness I felt with each vaccine included part of the mouth and gums. This is ongoing.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On 29-JAN-2016, the patient was vaccinated with expired dose of ZOSTAVAX (dose, frequency and route of administration were not reported, lot # K016324 with expiration date: 24-DEC-2015) as prevention of shingles. No adverse effects were reported. Additional information has been requested.
Soreness at the site of injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 (Lot number: ER8727) at the age of 26 years as dose 1 single for covid-19 immunisation. Relevant medical history included: "Allergy-Zithromax" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 09Apr2021, outcome "recovered" (2021), described as "Soreness at the site of injection". Therapeutic measures were not taken as a result of vaccination site pain.  Additional information: Facility where the most recent COVID-19 vaccine was administered:Other. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient received Hormonal Birth Control within 2 weeks of vaccination.Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Our facility only has the capability to store COVID19 vaccines in the refrigerator. Patient was given a vaccine that was outside of the 10 week expiration window. The 10 week expiration date was 6/10/22, patient was given the vaccine on 6/22/22. Patient has not reported any adverse events or symptoms to our facility.